|
Match
|
Document |
Document Title |
|
|
7589122 |
Method for soybean aphid population suppression and monitoring using aphid- and host-plant-associated semiochemical compositions
Soybean volatile compounds, soybean aphid-induced volatile compounds and soybean aphid sex pheromones are semiochemicals of the invention used to suppress soybean aphid population. Methyl...
|
|
|
7585893 |
Anti-cancer composition comprising DMXAA or related compound
The present invention relates to the use of compounds such as compounds of the xanthenone acetic acid class such as 5,6-dimethylxanthenone-4-acetic acid (DMXAA) for the treatment of cancer, wherein...
|
|
|
7553872 |
Compounds and compositions for delivering active agents
Carrier compounds and compositions therewith which are useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.
|
|
|
7538233 |
Coumarins as iNOS inhibitors
The present invention relates to coumarins of the formula (I):
that are useful as inhibitors of nitric oxide synthase. Pharmaceutical compositions and methods of using these compounds as...
|
|
|
7531646 |
β-D-ribosidase activity indicators with a chromogenic substrate
This invention provides a method of detecting enzyme activity on a solid medium. The enzyme substrate has a chromogenic portion comprising a catechol residue, in which a derivitising moiety is...
|
|
|
7524883 |
Eponemycin and epoxomicin analogs and uses thereof
The present invention provides compounds having formula (1): wherein R 1 -R 6 , A, J, D, E, G, Q, w, x, y, and z are as described generally and in classes and subclasses herein, and additionally...
|
|
|
7511034 |
Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
Novel dialkylhydroxybenzoic acid derivatives containing metal chelating groups are disclosed. The novel compounds are used as therapeutics for treating and/or preventing various medical...
|
|
|
7491746 |
Compounds, compositions and methods
Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
|
|
|
7488734 |
Methods of treating hormone-related conditions using thio-oxindole derivatives
The present invention provides methods of inducing contraception which includes delivering to a female a composition containing a compound of formula I, or tautomers thereof, in a regimen which...
|
|
|
7476673 |
Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors
Compounds of the formula
where the variables are as defined in the specification, are useful for preventing or treating emphysema and related pulmonary conditions of mammals and other diseases...
|
|
|
7429616 |
Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as antitumor compounds
The invention relates to the synthesis and complete stereochemical assignments of cytotoxic compounds such as compound 28-a and its stereoisomers:
The invention further provides processes for...
|
|
|
7399783 |
Methods for the treatment of scar tissue
A topical composition and method for the reduction of scar tissue and/or improving the appearance of scar tissue after it has formed. The topical composition includes one or more flavonoids...
|
|
|
7396856 |
Benzopyran analogs and their use for the treatment of glaucoma
Novel benzopyran analogs are disclosed. Also disclosed are methods for the lowering and controlling of normal or elevated intraocular pressure as well as a method for the treatment of glaucoma...
|
|
|
7332522 |
Liver function protecting or ameliorating agent
A liver function protecting or improving agent which comprises a compound represented by the formula (I)
{in the formula (I), R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 may be the...
|
|
|
7329687 |
Flavanoid compounds as chemotherapeutic, chemopreventive, and antiangiogenic agents
Compounds useful as chemotherapeutic, chemopreventive, and antiangiogenic agents are provided. The compounds are flavanoids, including flavanones, flavanols, and chalcones. The compounds have the...
|
|
|
7323452 |
Method for the accelerated in vivo removal of ethanol
A method for accelerating the process of removing ethanol from the blood through the use of certain additives that accelerate the metabolic oxidation of ethanol, and others which in addition act as...
|
|
|
7276491 |
Anticoagulant and fibrinolytic therapy using p38 MAP kinase inhibitors
Disclosed are methods for a treating a disease or condition relating to blood coagulation and fibrinolysis using p38 MAP kinase inhibitors.
|
|
|
7259185 |
Stable warfarin sodium liquid formulation and method of making same
A stable liquid composition comprising warfarin sodium, glycerin, an alcohol such as ethanol, and a pH buffer such as a phosphate buffer providing a pH above 7 is provided. The stability of the...
|
|
|
7256158 |
2,4,5,-trisubstituted phenylketo-enols for use as pesticides and herbicides
The invention relates to new phenyl-substituted cyclic ketoenols of the formula (I)
in which
Het represents one of the groups
wherein A, B, D, G, X, Y and Z have the meaning given in the...
|
|
|
7226945 |
Estrogen receptor-β ligands
A method for treating a disease associated with the estrogen receptor-β, comprising the step of administiering a therapeutically-effective amount of a compound that satifies the equation: K iαA...
|
|
|
7214706 |
Chroman derivatives as estrogenic compounds
The invention provides chroman compounds having Formula (1), wherein R 1 is (1C–4C)alkyl, (2C–4C)alkenyl or (2C–4C)alkynyl, and independently R 1 has a cis-orientation in relation to the...
|
|
|
7179838 |
Coumarin analog compounds for safer anticoagulant treatment
The present invention relates to the albumin-guided development of coumarin analogs and the analogs developed thereby. The coumarin analogs of the present invention are identified and isolated by...
|
|
|
7148253 |
4-thio coumarins
4-Thio substituted coumarin derivatives, 4,5-dithio substituted coumarin derivatives, and coumarin dimers are provided, as well as processes for their preparation. The invention also provides a...
|
|
|
7148252 |
Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis
This invention relates to methods for using benzopyranones, or their pharmaceutically acceptable salts, for treating or preventing a primary brain cancer or a brain metastasis. The benzopyranones...
|
|
|
7098244 |
Antibacterial agent
Provided is an antibacterial agent exhibiting an excellent antibacterial activity effect and exerting a mild influence on the environment and humans. The antibacterial agent of the present...
|
|
|
7094378 |
Method and apparatus for inactivation of biological contaminants using photosensitizers
Methods and apparatuses for treating fluids to inactivate microorganisms which may be present therein, said fluid containing one or more components selected from the group consisting of protein,...
|
|
|
7070968 |
DNA damaging agents in combination with tyrosine kinase inhibitors
The present invention relates to the signalling pathways connecting DNA damage, such as that induced by ionizing radiation or alkylating agents, and phosphorylation by tyrosine kinases.
|
|
|
7067142 |
Packaged rodenticide
A packaged animal poison includes a binder/rodenticide/bait mix molded into a cellulosic housing. The housing is covered with a removable cover. The housing defines an internal cavity in which the...
|
|
|
7060726 |
Antibacterial agent
Provided is an antibacterial agent exhibiting an excellent antibacterial activity effect and exerting a mild influence on the environment and humans. The antibacterial agent of the present...
|
|
|
7056653 |
Detection of binding of charged species using PH- or potential-sensitive probes
The extent of binding of a moiety, such as a biomolecule, to a surface, where the local environment at the surface has a pH or surface potential which is altered upon binding of the moiety, is...
|
|
|
7053116 |
Methods for protecting cells from amyloid toxicity and for inhibiting amyloid protein production
In accordance with the present invention, there are provided novel methods of blocking amyloid protein toxicity in cells using polycylic compounds. Also provided are novel methods of decreasing...
|
|
|
7008632 |
Combination of biological and chemical agents to combat rodents
The present invention relates to compositions comprising sporocysts of at least one parasitic single-cell organism and at least one anticoagulant, and to their use for controlling harmful rodents.
|
|
|
6987127 |
Regulation of NAD(P)H oxidase growth and transcription in melanoma cells
Malignant melanoma cells spontaneously generate reactive oxygen species (ROS) that promote constitutive activation of the transcription factor nuclear factor-kB (NF-kB). Although antioxidants and...
|
|
|
6916846 |
Coumermycin analogs as chemical dimerizers of chimeric proteins
Coumermycin analogs of general formula I:
wherein X, a linking group, is selected from the group consisting of alkyl, aryl, diaryl, substituted alkyl, substituted aryl, alkyl with...
|
|
|
6908942 |
6-amino-2,2-dimethyl-3,4,6-trisubstituted benzopyran derivatives and their construction by parallel synthesis on solid-phase
The present invention provides (i) 6-amino-2,2-dimethyl-3,4,6-trisubstituted benzopyran derivatives; (ii) a process for synthesizing benzopyran derivatives with high efficiency by parallel...
|
|
|
6884818 |
Pharmaceutical compositions containing 8-chloro-3 (β-diethylaminoethyl)-4-methyl-7-ethoxycarbonylmethoxy coumarin base and the salts thereof with cholesterol-lowering activity
The present invention concerns the use of cloricromene (8-chloro-3(β-diethylaminoethyl)-4-methyl-7-ethoxycarbonylm
ethoxy coumarin) base and the salts thereof to prepare pharmaceutical...
|
|
|
6861075 |
Biocidal compositions comprising an aerated gel containing hydrophobic silica
A storage-stable biocidal aerated gel composition comprises from 30 to 97% by weight of water, from 0.2 to 5% by weight of a gelling agent selected from xanthan gum, sodium alginate and neutralised...
|
|
|
6858645 |
Tartrate salts of (R) -3-N,N- dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1- benzopyran-5-carboxamide
A new salt (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzop
yran-5-carboxamide hydrogen tartrate, particularly the (2R,3R)-tartrate thereof, most particularly the...
|
|
|
6855734 |
Glycine betaine and its use
Pharmaceutical uses of glycine betaine, such as for the treatment of thromboses not induced by hyperhomocystenemia or homocystinuria, of blood disorders, such as blood coagulation, thrombi formation.
|
|
|
6849658 |
Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them
The invention concerns bi-aromatic compounds of formula (I) in which Ar represents (a), Z being O or S, R 1 is CH 3 , —CH 2 —O—R 6 , —OR 6 or —COR 7 ; R 2 is —OR 8 , —SR 8 or a...
|
|
|
6833362 |
Method and composition for the accelerated in vivo removal of ethanol
A composition for accelerating the disposal of ethanol from bodily fluid. Certain additives can accelerate the metabolic oxidation of ethanol, and others in addition act as catalysts or...
|
|
|
6831098 |
Hesperetin pro-forms with enhanced bioavailablility
A hesperitin pro-form is provided. The invention provides both a hydrophilic and lipophilic hesperetin pro-form. A pharmaceutical composition is provided which is suitable for topical or oral...
|
|
|
6818668 |
5-alkyl-7-alkylcarbonate-isoflavone ester and related method
A compound is provided for increasing the concentration of a parent isoflavone in a subject in vivo. The parent isoflavone has a skeletal structure including a 5 position and a 7 position, a 5...
|
|
|
6794384 |
Hydroxylation activated drug release
The present invention concerns prodrugs whose aromatic oxidation, particularly their enzymatic aromatic hydroxylation, results in their activation by the release of a drug moiety. It particularly...
|
|
|
6780887 |
Anti-ischemic compounds
The present invention is related to a compound of formula (I), salts and pro-drugs of the compound (I) and methods for treating and/or preventing partial or total ischemia, methods for treating...
|
|
|
6774141 |
Calanolide and related antiviral compounds, compositions, and uses thereof
The present invention provides novel antiviral compounds, refered to as calanolides, related compounds, and their derivatives, which may be isolated from plants, or derived from compounds from...
|
|
|
6773727 |
Use of gossypol and related terpenes for control of urban and agricultural pests
Low concentrations of gossypol and related phyllophage toxins from cotton improve the effectiveness of insecticidal agents against social insects, including cockroaches, and particularly termites...
|
|
|
6750249 |
Controlled release oral preparations of esculetin and its derivatives
The present invention relates to an oral preparation of esculetin with controlled release. The oral preparation of esculetin with controlled release of the present invention comprises a gel-forming...
|
|
|
6747060 |
Non-natural galanin receptor ligands
Compounds which are non-natural galanin receptor ligands are disclosed. The ligands are of small size, have agonist or antagonist galanin activity and may cross the blood-brain barrier to displace...
|
|
|
6737439 |
Aromatase inhibitors from Broussonetia papyrifera
A composition and method of cancer treatment is disclosed. The composition and method utilized the extract of B. papyrifera , or compounds included therein having aromatase inhibition properties,...
|